CN101384618A - 癌中capcna蛋白-蛋白相互作用的肽基抑制 - Google Patents
癌中capcna蛋白-蛋白相互作用的肽基抑制 Download PDFInfo
- Publication number
- CN101384618A CN101384618A CNA2007800052894A CN200780005289A CN101384618A CN 101384618 A CN101384618 A CN 101384618A CN A2007800052894 A CNA2007800052894 A CN A2007800052894A CN 200780005289 A CN200780005289 A CN 200780005289A CN 101384618 A CN101384618 A CN 101384618A
- Authority
- CN
- China
- Prior art keywords
- capcna
- cancer
- composition
- peptide
- cell
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4738—Cell cycle regulated proteins, e.g. cyclin, CDC, INK-CCR
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Toxicology (AREA)
- Cell Biology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Oncology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US74331306P | 2006-02-17 | 2006-02-17 | |
| US60/743,313 | 2006-02-17 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN101384618A true CN101384618A (zh) | 2009-03-11 |
Family
ID=38235155
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNA2007800052894A Pending CN101384618A (zh) | 2006-02-17 | 2007-02-16 | 癌中capcna蛋白-蛋白相互作用的肽基抑制 |
Country Status (9)
| Country | Link |
|---|---|
| US (3) | US8653039B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1989225A2 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2009527498A (cg-RX-API-DMAC7.html) |
| CN (1) | CN101384618A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2007217037A1 (cg-RX-API-DMAC7.html) |
| BR (1) | BRPI0707948A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2638866C (cg-RX-API-DMAC7.html) |
| EA (1) | EA200801847A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2007098415A2 (cg-RX-API-DMAC7.html) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107404876A (zh) * | 2015-04-10 | 2017-11-28 | 雷尔有限责任公司 | 抗癌治疗剂 |
| CN110300761A (zh) * | 2016-12-15 | 2019-10-01 | 国家生物技术研究所公司 | 抗pcna单克隆抗体及其用途 |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EA200801847A1 (ru) * | 2006-02-17 | 2009-02-27 | Индиана Юниверсити Рисерч Энд Текнолоджи Корпорейшн | ПЕПТИДНОЕ ИНГИБИРОВАНИЕ ВЗАИМОДЕЙСТВИЯ caPCNA ПРИ РАКЕ |
| WO2008036929A2 (en) * | 2006-09-21 | 2008-03-27 | Alnylam Pharmaceuticals, Inc. | Complex for transferring an anionic substance into a cell |
| GB0803352D0 (en) | 2008-02-22 | 2008-04-02 | Ntnu Technology Transfer As | Oligopeptidic compounds and uses thereof |
| CA2732737C (en) * | 2008-07-24 | 2019-03-05 | Indiana University Research And Technology Corporation | Cancer peptide therapeutics |
| FR2942798B1 (fr) * | 2009-03-05 | 2011-04-08 | Centre Nat Rech Scient | Peptides utilisables pour le traitement de la leucemie lymphoide chronique |
| WO2011044374A1 (en) * | 2009-10-07 | 2011-04-14 | Indiana University Research And Technology Corporation | Capcna peptide therapeutics for cancer |
| EP2538959A1 (en) * | 2010-02-24 | 2013-01-02 | Institut National de la Santé et de la Recherche Médicale | Compounds for the treatment of inflammation and neutropenia |
| JP2013522613A (ja) * | 2010-03-18 | 2013-06-13 | アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル | 化学療法に対する応答性を予測するための方法 |
| US9475840B2 (en) | 2012-02-27 | 2016-10-25 | Universitat De Barcelona | Protease-resistant compounds useful as shuttles through the blood-brain barrier and shuttle-cargo constructs |
| GB201214007D0 (en) * | 2012-08-07 | 2012-09-19 | Scancell Ltd | Anti-tumour immune responses to modified self-epitopes |
| GB201815041D0 (en) | 2018-09-14 | 2018-10-31 | Scancell Ltd | Epitopes |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5935797A (en) | 1994-06-16 | 1999-08-10 | Stanford University | Interaction of MHC Class II proteins with members of the PCNA family of proteins |
| GB9509557D0 (en) * | 1995-05-11 | 1995-07-05 | Univ Dundee | PCNA binding substance |
| JP2002518341A (ja) * | 1998-06-15 | 2002-06-25 | アーチ・デヴェロップメント・コーポレイション | 放射線療法と抗血管形成因子の組み合わせ |
| US7294471B2 (en) | 2002-02-27 | 2007-11-13 | Cskeys, Llc | Method for purifying cancer-specific proliferating cell nuclear antigen |
| MX2007013584A (es) | 2005-04-27 | 2008-04-22 | Univ Indiana Res & Tech Corp | Anticuerpos de isoforma de cspcna y sus usos. |
| DE602006021178D1 (de) | 2005-06-27 | 2011-05-19 | Univ Indiana Res & Tech Corp | Cspcna-isoform-modifikationen und anwendungen davon |
| EA200801847A1 (ru) * | 2006-02-17 | 2009-02-27 | Индиана Юниверсити Рисерч Энд Текнолоджи Корпорейшн | ПЕПТИДНОЕ ИНГИБИРОВАНИЕ ВЗАИМОДЕЙСТВИЯ caPCNA ПРИ РАКЕ |
-
2007
- 2007-02-16 EA EA200801847A patent/EA200801847A1/ru unknown
- 2007-02-16 CA CA2638866A patent/CA2638866C/en active Active
- 2007-02-16 AU AU2007217037A patent/AU2007217037A1/en not_active Abandoned
- 2007-02-16 CN CNA2007800052894A patent/CN101384618A/zh active Pending
- 2007-02-16 JP JP2008555524A patent/JP2009527498A/ja active Pending
- 2007-02-16 BR BRPI0707948-6A patent/BRPI0707948A2/pt not_active Application Discontinuation
- 2007-02-16 EP EP07757135A patent/EP1989225A2/en not_active Withdrawn
- 2007-02-16 WO PCT/US2007/062335 patent/WO2007098415A2/en not_active Ceased
- 2007-02-16 US US12/279,028 patent/US8653039B2/en active Active
-
2014
- 2014-02-18 US US14/182,550 patent/US9187526B2/en active Active
-
2015
- 2015-10-29 US US14/926,904 patent/US20160304559A1/en not_active Abandoned
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107404876A (zh) * | 2015-04-10 | 2017-11-28 | 雷尔有限责任公司 | 抗癌治疗剂 |
| CN110300761A (zh) * | 2016-12-15 | 2019-10-01 | 国家生物技术研究所公司 | 抗pcna单克隆抗体及其用途 |
| CN110300761B (zh) * | 2016-12-15 | 2023-05-09 | 国家生物技术研究所公司 | 抗pcna单克隆抗体及其用途 |
Also Published As
| Publication number | Publication date |
|---|---|
| US9187526B2 (en) | 2015-11-17 |
| EP1989225A2 (en) | 2008-11-12 |
| BRPI0707948A2 (pt) | 2011-05-17 |
| US20140296156A1 (en) | 2014-10-02 |
| US20090232882A1 (en) | 2009-09-17 |
| CA2638866A1 (en) | 2007-08-30 |
| US20160304559A1 (en) | 2016-10-20 |
| WO2007098415A3 (en) | 2007-12-13 |
| US8653039B2 (en) | 2014-02-18 |
| AU2007217037A1 (en) | 2007-08-30 |
| WO2007098415A2 (en) | 2007-08-30 |
| CA2638866C (en) | 2015-11-10 |
| JP2009527498A (ja) | 2009-07-30 |
| EA200801847A1 (ru) | 2009-02-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US9187526B2 (en) | Peptide based inhibition of caPCNA interaction in cancer | |
| US8278278B2 (en) | Cell proliferation reducing cancer specific PCNA peptides | |
| CN102015758B (zh) | 寡肽化合物及其应用 | |
| EP2913057B1 (en) | Cancer peptide therapeutics | |
| JP2009527498A5 (cg-RX-API-DMAC7.html) | ||
| CN114026114A (zh) | 用于治疗再灌注损伤的bnip3肽 | |
| Puszko et al. | Urea moiety as amide bond mimetic in peptide-like inhibitors of VEGF-A165/NRP-1 complex | |
| US9593148B2 (en) | DPP8 and DPP9 peptide inhibitors | |
| US20240368566A1 (en) | Pyk2-derived peptides for inhibiting invadopodia-mediated cancer metastasis | |
| US20140005119A1 (en) | COMPOSITIONS AND METHODS FOR INHIBITING THE ACTIVITY OF P110a MUTANT PROTEINS | |
| Bendzunas | All Hydrocarbon Stapled Peptides as Allosteric Modulators of Protein-Protein Interactions | |
| EP2578227B1 (en) | Cancer therapy method | |
| KR20250047483A (ko) | Braf 활성 억제 단백질 및 이를 유효성분으로 함유하는 암질환 예방 또는 치료용 조성물 | |
| HK1214177B (en) | Cancer peptide therapeutics | |
| ITRM20090232A1 (it) | Peptide capace di disassemblare i complessi proteici fra la proteina p53 mutata his 273 e la proteina oncosoppressiva p73 in cellule tumorali e suoi usi in campo medico. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Open date: 20090311 |